Logan Capital Management Inc. Sells 203 Shares of CME Group Inc. (NASDAQ:CME)

Logan Capital Management Inc. lowered its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 35.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 371 shares of the financial services provider’s stock after selling 203 shares during the quarter. Logan Capital Management Inc.’s holdings in CME Group were worth $78,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Norges Bank bought a new stake in CME Group during the fourth quarter worth about $959,260,000. Capital Wealth Planning LLC bought a new stake in CME Group during the fourth quarter worth about $253,563,000. Capital World Investors grew its stake in CME Group by 8.7% during the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares during the last quarter. Morgan Stanley grew its stake in CME Group by 31.5% during the third quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock worth $972,863,000 after buying an additional 1,163,103 shares during the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc bought a new stake in CME Group during the fourth quarter worth about $113,772,000. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on CME. JPMorgan Chase & Co. increased their price target on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Rosenblatt Securities reissued a “sell” rating and set a $187.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 price target (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Argus increased their price target on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Finally, Bank of America increased their price target on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $217.80.

View Our Latest Stock Analysis on CME Group

Insiders Place Their Bets

In other news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the sale, the director now owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction on Monday, April 29th. The shares were sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the completion of the sale, the chief executive officer now owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 51,290 shares of company stock worth $10,807,380. Company insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.4 %

CME opened at $198.50 on Tuesday. The firm’s fifty day moving average is $209.39 and its two-hundred day moving average is $210.51. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.01 and a current ratio of 1.01. The firm has a market cap of $71.47 billion, a PE ratio of 22.58, a price-to-earnings-growth ratio of 5.27 and a beta of 0.52. CME Group Inc. has a twelve month low of $177.04 and a twelve month high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s revenue for the quarter was up 3.2% compared to the same quarter last year. During the same period last year, the business posted $2.42 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 9.72 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 annualized dividend and a yield of 2.32%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.